ZSG’s platform technology will address the major pain points in key areas of genomics research (what can be studied, the pace at which data can be understood, and the cost of discovery research) and thereby become a valued resource to the genomics industry, molecular diagnostics, and the future of personalized medicine. The ZSG approach provides key answers to market challenges:
• Dramatically superior read lengths: 20,000+ bp
• Single-molecule capability
• Very competitive costs and throughput
• The ability to perform applications that cannot be done today
The Company created its unique approach by combining existing commercially proven and available capabilities into a powerful, patented technology. ZSG technology provides high-quality genetic sequencing with the exceptional advantage of extremely long read lengths and single-molecule sampling. When commercialized, ZSG’s technology will provide solutions that make it unique in the marketplace, with significant cost efficiencies.